UNSPSC 85822104: Measurement of peripheral nervous conductivity, sensory, open approach

This classification denotes the group of activities that yields a measurement intervention or procedure to measurement of peripheral nervous conductivity, sensory, open approach. This measurement intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 4A01029

UNSPSC 85822104 Measurement of peripheral nervous conductivity, sensory, open approach is a Commodity code that spans diagnostic and therapeutic neurological testing services, though the recent state and local opportunities posted under this code show minimal alignment with the nominal scope. The code appears underutilized for its stated purpose; recent postings include virtual urgent care services (Inland Empire Health Plan), general medical services (DeKalb County), and Program of All Inclusive Care for the Elderly (Nevada Health Authority)—none of which directly involve peripheral nerve conductivity measurement or sensory testing in any form. The issuing bodies span state health authorities, county health systems, and regional health plans across California, Georgia, and Nevada, reflecting a mix of Medicaid-focused and regional delivery organizations rather than specialized diagnostics providers.

The mismatch between code taxonomy and actual posted opportunities signals that either the category assignment is incorrect, the code sees little relevant activity under its true definition, or procurement offices are mis-tagging unrelated health services. Geographic activity centers on California (IEHP, San Mateo County), Nevada (two Nevada Health Authority RFPs), and Georgia (DeKalb County), with no identifiable pattern of repeat buyers or concentrated demand. No recent opportunities explicitly solicit peripheral nerve testing, conductivity measurement, or related electrophysiological services. Business development professionals evaluating this code should treat it as a signal to verify actual customer demand through direct outreach to state health departments, hospital systems, and diagnostic laboratories rather than relying on recent procurement signals, which currently offer limited decision support.